We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Name | Symbol | Market | Type |
|---|---|---|---|
| AstraZeneca PLC | NASDAQ:AZN | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.59 | -0.77% | 75.76 | 74.65 | 76.55 | 75.93 | 75.545 | 75.84 | 6,457,295 | 01:00:00 |
From May 2019 to May 2024
--Germany's vaccine committee Stiko is ready to recommend AstraZeneca's coronavirus vaccine to those 65 and over, according to documents seen by German daily newspaper Frankfurter Allgemeine Zeitung, the paper reported Thursday.
--A new study in Belgium, published Wednesday, on the vaccine's suitability for seniors was one of the decisive factors for the commission, and seniors could receive doses from next week, the newspaper reports.
--AstraZeneca wasn't immediately available for comment, while the committee declined to comment on the story to Dow Jones Newswires.
Full story (in German): https://bit.ly/3riraU6
Write to Barcelona editors at barcelonaeditors@dowjones.com
(END) Dow Jones Newswires
March 04, 2021 08:44 ET (13:44 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year AstraZeneca Chart |
1 Month AstraZeneca Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
